Skip to main content

Longer gap in Pfizer-BioNTech Covid vaccine boosts antibody levels: Study

A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found.

from Home Page https://ift.tt/3x1Y3qp

Comments

Popular posts from this blog